BCG vaccination and GAD65 and IA-2 autoantibodies in autoimmune diabetes in southern India.
This paper reports a study to determine whether BCG vaccination is associated with an increase or decrease in GAD65 and I-A2 autoantibodies in cases of IDDM and NIDDM in southern India. It is concluded that BCG vaccination has an immunomodulatory role in these diseases.
Sanjeevi
C B
CB
Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden. sanjeevi.carani@molmed.ki.se
Das
Ashok K
AK
Shtauvere-Brameus
A
A
D001323:Autoantibodies / Q000276:immunology*; D001500:BCG Vaccine / Q000009:adverse effects / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000453:epidemiology / Q000276:immunology*; D005968:Glutamate Decarboxylase / Q000276:immunology*; D006801:Humans; D007194:India / Q000453:epidemiology; D007527:Isoenzymes / Q000276:immunology*
D001323:Autoantibodies; D001500:BCG Vaccine; C096322:ICA512 autoantibody; D007527:Isoenzymes; D005968:Glutamate Decarboxylase; C401141:glutamate decarboxylase 2